PHENYLETHYLMALONAMIDE (PEMA) - IMPORTANT METABOLITE OF PRIMIDONE

[1] BOGUE JY, 1956, ACTA NEUROL BELG, V56, P640

[2] BUTLER TC, 1956, P SOC EXP BIOL MED, V93, P544

[3] COOPER JR, 1955, J PHARMACOL EXP THER, V114, P409

[4] FREY HH, 1960, ARCH INT PHARMACOD T, V128, P281

[5] RELATIONSHIP OF ANTICONVULSANT PROPERTIES OF PRIMIDONE TO PHENOBARBITAL [J]. EPILEPSIA, 1970, 11 (03) : 293 - +

[6] HANDLEY R, 1952, LANCET, V262, P742

[7] LOUS P, 1954, ACTA PHARMACOL TOX, V10, P166

[8] PRICHARD JW, 1969, J PHARMACOL EXP THER, V166, P170

[9] REYNOLDS EH, 1971, NEUROLOGY, V21, P394

[1] BOGUE JY, 1956, ACTA NEUROL BELG, V56, P640

[2] BUTLER TC, 1956, P SOC EXP BIOL MED, V93, P544

[3] COOPER JR, 1955, J PHARMACOL EXP THER, V114, P409

[4] FREY HH, 1960, ARCH INT PHARMACOD T, V128, P281

[5] RELATIONSHIP OF ANTICONVULSANT PROPERTIES OF PRIMIDONE TO PHENOBARBITAL [J]. EPILEPSIA, 1970, 11 (03) : 293 - +

[6] HANDLEY R, 1952, LANCET, V262, P742

[7] LOUS P, 1954, ACTA PHARMACOL TOX, V10, P166

[8] PRICHARD JW, 1969, J PHARMACOL EXP THER, V166, P170

[9] REYNOLDS EH, 1971, NEUROLOGY, V21, P394